Citadel Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.63M | Sell |
82,800
-65,100
| -44% | -$5.37M | ﹤0.01% | 3883 |
|
|
2025
Q4 | $12.6M | Buy |
147,900
+23,300
| +19% | +$1.91M | ﹤0.01% | 2938 |
|
|
2025
Q3 | $9.69M | Sell |
124,600
-30,800
| -20% | -$2.41M | ﹤0.01% | 3325 |
|
|
2025
Q2 | $12.2M | Sell |
155,400
-39,900
| -20% | -$2.98M | ﹤0.01% | 2762 |
|
|
2025
Q1 | $14.2M | Sell |
195,300
-377,600
| -66% | -$27M | ﹤0.01% | 2429 |
|
|
2024
Q4 | $42.4M | Sell |
572,900
-153,600
| -21% | -$10.8M | 0.01% | 1431 |
|
|
2024
Q3 | $47.9M | Buy |
726,500
+235,600
| +48% | +$17.1M | 0.01% | 1256 |
|
|
2024
Q2 | $45.3M | Sell |
490,900
-448,200
| -48% | -$39.7M | 0.01% | 1222 |
|
|
2024
Q1 | $89.7M | Buy |
939,100
+288,100
| +44% | +$24.2M | 0.02% | 769 |
|
|
2023
Q4 | $49.6M | Buy |
651,000
+429,800
| +194% | +$29.9M | 0.01% | 1190 |
|
|
2023
Q3 | $15.3M | Buy |
221,200
+108,000
| +95% | +$8.68M | ﹤0.01% | 2165 |
|
|
2023
Q2 | $10.7M | Sell |
113,200
-495,100
| -81% | -$43M | ﹤0.01% | 2592 |
|
|
2023
Q1 | $50.3M | Buy |
608,300
+323,100
| +113% | +$25.4M | 0.01% | 1055 |
|
|
2022
Q4 | $21.3M | Buy |
285,200
+18,100
| +7% | +$1.39M | 0.01% | 1905 |
|
|
2022
Q3 | $22.1M | Sell |
267,100
-126,200
| -32% | -$12.1M | 0.01% | 1775 |
|
|
2022
Q2 | $37.4M | Buy |
393,300
+205,400
| +109% | +$21.3M | 0.01% | 1254 |
|
|
2022
Q1 | $22.1M | Sell |
187,900
-124,100
| -40% | -$13.9M | ﹤0.01% | 1871 |
|
|
2021
Q4 | $40.4M | Sell |
312,000
-4,100
| -1% | -$478K | 0.01% | 1343 |
|
|
2021
Q3 | $35.8M | Buy |
316,100
+62,100
| +24% | +$7.09M | 0.01% | 1404 |
|
|
2021
Q2 | $26.3M | Buy |
254,000
+85,000
| +50% | +$8.01M | 0.01% | 1758 |
|
|
2021
Q1 | $14.1M | Sell |
169,000
-88,600
| -34% | -$7.49M | ﹤0.01% | 2462 |
|
|
2020
Q4 | $23.5M | Buy |
257,600
+25,400
| +11% | +$2.11M | 0.01% | 1643 |
|
|
2020
Q3 | $18.5M | Sell |
232,200
-63,500
| -21% | -$4.95M | 0.01% | 1650 |
|
|
2020
Q2 | $20.4M | Buy |
295,700
+109,700
| +59% | +$7.8M | 0.01% | 1485 |
|
|
2020
Q1 | $11.7M | Sell |
186,000
-194,100
| -51% | -$14M | 0.01% | 1703 |
|
|
2019
Q4 | $29.6M | Sell |
380,100
-85,200
| -18% | -$6.65M | 0.01% | 1138 |
|
|
2019
Q3 | $34.1M | Buy |
465,300
+173,700
| +60% | +$12.2M | 0.02% | 1025 |
|
|
2019
Q2 | $18M | Sell |
291,600
-207,300
| -42% | -$12.5M | 0.01% | 1518 |
|
|
2019
Q1 | $31.8M | Buy |
498,900
+269,400
| +117% | +$15.4M | 0.02% | 980 |
|
|
2018
Q4 | $11.7M | Sell |
229,500
-186,000
| -45% | -$9.41M | 0.01% | 1721 |
|
|
2018
Q3 | $24.1M | Buy |
415,500
+112,200
| +37% | +$5.49M | 0.01% | 1249 |
|
|
2018
Q2 | $14.7M | Buy |
303,300
+121,200
| +67% | +$5.66M | 0.01% | 1578 |
|
|
2018
Q1 | $8.47M | Sell |
182,100
-125,400
| -41% | -$5.45M | ﹤0.01% | 1894 |
|
|
2017
Q4 | $11.6M | Sell |
307,500
-1,200
| -0.4% | -$44K | 0.01% | 1589 |
|
|
2017
Q3 | $11.2M | Buy |
308,700
+136,500
| +79% | +$5.21M | 0.01% | 1500 |
|
|
2017
Q2 | $6.79M | Sell |
172,200
-94,800
| -36% | -$3.46M | 0.01% | 1798 |
|
|
2017
Q1 | $8.37M | Buy |
267,000
+60,900
| +30% | +$1.91M | 0.01% | 1572 |
|
|
2016
Q4 | $6.44M | Buy |
206,100
+51,300
| +33% | +$1.66M | 0.01% | 1733 |
|
|
2016
Q3 | $6.22M | Sell |
154,800
-91,800
| -37% | -$3.46M | 0.01% | 1764 |
|
|
2016
Q2 | $8.2M | Buy |
246,600
+43,800
| +22% | +$1.5M | 0.01% | 1400 |
|
|
2016
Q1 | $5.96M | Buy |
202,800
+7,200
| +4% | +$199K | 0.01% | 1603 |
|
|
2015
Q4 | $5.15M | Sell |
195,600
-118,800
| -38% | -$3.09M | 0.01% | 1796 |
|
|
2015
Q3 | $7.45M | Sell |
314,400
-133,200
| -30% | -$3.21M | 0.01% | 1572 |
|
|
2015
Q2 | $10.6M | Buy |
447,600
+211,200
| +89% | +$4.77M | 0.01% | 1435 |
|
|
2015
Q1 | $5.61M | Sell |
236,400
-60,000
| -20% | -$1.35M | 0.01% | 1917 |
|
|
2014
Q4 | $6.29M | Buy |
296,400
+82,800
| +39% | +$1.66M | 0.01% | 1773 |
|
|
2014
Q3 | $3.64M | Buy |
213,600
+1,800
| +0.8% | +$28.4K | ﹤0.01% | 2272 |
|
|
2014
Q2 | $3.03M | Sell |
211,800
-68,400
| -24% | -$927K | ﹤0.01% | 2326 |
|
|
2014
Q1 | $3.46M | Sell |
280,200
-241,200
| -46% | -$2.78M | ﹤0.01% | 2092 |
|
|
2013
Q4 | $5.71M | Buy |
521,400
+178,800
| +52% | +$2.02M | 0.01% | 1585 |
|
|
2013
Q3 | $3.98M | Sell |
342,600
-52,200
| -13% | -$611K | 0.01% | 1765 |
|
|
2013
Q2 | $4.42M | Buy |
+394,800
| New | +$4.67M | 0.01% | 1688 |
|
Other funds holding EW
VCM
VPM
Citadel Advisors's EW Position: Q1 2026 in Review
Citadel Advisors reduced its Edwards Lifesciences (EW) stake by 76% in Q1 2026, selling an estimated $139M and leaving 519,031 shares worth $41.6M. The position accounts for 0.01% of the portfolio, ranked #1533.
Citadel Advisors first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $996M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Citadel Advisors held 519,031 shares of Edwards Lifesciences worth $41.6M as of Q1 2026.
- Citadel Advisors sold 1,684,896 Edwards Lifesciences shares in Q1 2026, an estimated $139M.
- Edwards Lifesciences made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1533 holding.
- Citadel Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- Citadel Advisors's Edwards Lifesciences position peaked at $996M in Q2 2025.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.